88 (look-see) "Tickers" Double 00 / $20.00

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
88 (look-see) "Tickers"
Double 00 / $20.00

Charts and logos linked to updates.

PPS showing is from date called here.


PoemStone's triple 000 $AFPW Shares Outs
MoneyMaker's Triple 000 $CTKH .0003 Huge

$STEV  from 3/4/14 Stocktillyoudrop $0.

$APRI. ascending triangle $2.60 10-K &am

$ISR breakout $1.21 10-Q 2/14/14 O/S 41,

$CUR gap breakout Pr $4.00 10-K 3/14/14


DEPO at resistance $13.50 Shares Outsta

$GEPC penny climber $0.26 Shares Outstan

$CPST  climber & gap $2.32 from 12/

$LTS recovery at resistance $3.00 from 1

$ECOB  Pr $0.0033 Jacuzzi Selects Eco B

$BCLI near resistance $0.284 10-Q 11/14

$CLIR solid upturn $11.37 from 12/17/13

$IDST breakout new volume climber $0.09

$LBTG triple 000 up turn $0.0012 from Mo


$SVFC at breakout $0.0074 from 1/25/14 $


$HPTG new volume - new technology $0.76


$DKAM at support $0.0160 called 1/10/14

$BLUU at support $0.0142 called 1/14/14

$LIVE at support $7.93 from PYCKtradr Sh


$CBYI new volume triple 000 from FLA CBY

$SYN a rising flag $2.89 from  12/10/13

$PVCT higher lows after correction  $2


$POETF climber $1.30 from 11/29/13 $0.55


$GRLT  off bottom & gap & Pr $0


$PIHN new volume upturn $0.0107 from inn


$NGMC new volume spike. $0.05 from cabro


$ROSV new volume called James 719 - 3/10


$TNKE  consolidation rebound called PYC


$GRNH  bull flag  $0.50 called by stockstock 3/11/14


$CORT at breakout  $4.08 called 12/15/1


SNMX 9 month climber  $9.35 called 1/1

$JAKK  breakout  $7.45 JAKKS Pacific R

$UBRG  at breakout  $0.0016 Shares Out

$NDZ  4th breakout $10.07 called 3/7/13

$IFON gap breakout PR  $3.95 Preferred

$AEMD balloon $0.20 March 05, 2014, 08:2

$PPHM record volume called 9/9/13 ( $1.5

$APPY new volume candle $2.59 called 1/1

$HZNP called 11/9/13 at  $4.86 outstand

$SEGI  new volume upturn called 2/28 by

$MRIB ready again / called 10/6/13 at $0

$LIVE  called 1/16/2014 $3.30 Shares Ou

$SMT called 8/10/2013 $2.32 Feb 6, 2014

$OCLR called 12/1/13 at $2.25 Shares Out

$QTWW called 10/5/13 at $4.28 Shares Out

$WWAV called 11/15/13 $21.61 Dec 31, 201

$VEND called 1/11/14 recovery climber $2

$CASM called 11/2/13 $1.48 Shares Outsta

$CIDM called 10/20/13 $1.77 Shares Outst

$GTAT called 9/21/13 GTAT Chart $8.22 Ch

$COHO called 12/31/13 $0.002 off bottom

$AXIH  $0.98 consolidation called 12/9/1

$PLUG $2.06 gaps & candles breakout


$NVLX breakout candles called $0.15 PYCK

$PTIE called 10/26/13 $3.83 Shares Outs


$ARTH new climber $ 0.33 called 12/31/20

$DMPI  new climber $1.44 Shares Outstan

$CYNAF correcting a new high $1.17 Share

$ISIG  at breakout $2.90 called 2/26/14

$VUZI at resistance  $3.04 Shares Outst

$IFUE climber $0.13 called 2/26/14 Share

$BEE breakout $9.70 called 2/25/14 Not A

$ETEK at breakout  $0.02 called 2/26/12

$HPNN Pr  $0.0015 called 2/20/14 Shalom


$VOIS PRs (takeover) $0.003 called 2/21/

$MYEC upturn $0.0033 called 2/13/14 stoc

$PULS PR breakout  $3.50 called 2/21/14

$LOJN  breakout gap & candles  $4.18

$RTRX double gap breakout. $16.50 called


$ARTX at breakout  $2.87 Shares Outstan


$XXII climber  $3.10 Shares Outstanding


$IO  at breakout PR $3.15 called 2/12/1

$EDXC breakout candle  $0.289 Shares Ou

$FRCN  triple 000 $0.0006 called 2/9/14

$YOD at breakout $3.31 Shares Outstandin

$WARM  consolidation channel $0.54 Shar

$OPTT uptick at support $2.32 As of Nove


$WWE 18 month climb $13.32 Called 11/1

$PLPL new volume breakout $0.43 (1/15/14


$RSYS breakout candle $2.65 (1/14/14) Sh


$KGET double cup breakout gap balloon $0

$ENSV stair step $1.87 Shares Outstandin


$MRNA candle $0.76 PR Shares Outstanding

$ERBB breakout candles $0.0039 Shares Ou

$HZNP $4.86 up volume & gap outstandi

$FNMA $2.41 climber Shares Outstanding 1,

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 527

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 116

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 350

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 63

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 554

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 356

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 270

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 462

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 284

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Top Large-Cap Stocks to Watch for Future Growth Opportunities

Updated Category News Views 409

Emerging Large-Cap Stocks: Evaluating Performance Last week proved to be a robust period for several large-cap stocks, demonstrating significant gains on the market. If you're looking to expand your portfolio with top performers, it's essential to keep an eye on these standout companies. AeroVironment's Spectacular Performance AeroVironment, Inc. (NASDAQ: AVAV) saw its...

Continue Reading
Celebrating 80 Years of Unity: Manchester Congress Reimagined

Updated Category News Views 373

Celebrating the Legacy of the Manchester Congress The Pan-African Progressive Front (PPF), working hand in hand with various organizations, has embarked on an exciting journey to commemorate the 80th anniversary of the historic Manchester Congress. This momentous event, pivotal in shaping pan-African unity and liberation movements, is set to stir conversations and inspire...

Continue Reading
Stifel Optimistic on Nurix's NX-5948 Ahead of ASH Presentation

Updated Category News Views 86

Stifel's Positive Adjustment for Nurix Therapeutics Stock Stifel, a well-known financial services firm, has shown renewed confidence in Nurix Therapeutics Inc. (NASDAQ: NRIX) by increasing its price target for the company’s shares from $30 to $34 while keeping a Buy rating. This optimistic outlook reflects anticipation surrounding Nurix's ongoing drug trials,...

Continue Reading
Josh Christie Steps Up as Chief Managing Partner at Ice Miller

Updated Category News Views 266

Josh Christie Steps Up as Chief Managing Partner at Ice Miller Ice Miller is excited to share that Joshua Christie will serve as its new Chief Managing Partner starting January 1, 2026. His election reflects the firm’s trust in his leadership capabilities and vision for the future. Based in the Indianapolis office, Christie has been an integral part of Ice Miller since...

Continue Reading
IPSEN's Latest Buy-Back Initiative: Weekly Summary Insights

Updated Category News Views 156

IPSEN's Buy-Back Program Overview IPSEN has embarked on an exciting buy-back program aimed at enhancing shareholder value by strategically purchasing its own shares. This initiative is not only an investment in its financial health but also reflects the confidence IPSEN has in its future. As of Week 33, 2025, a comprehensive overview of the transactions executed...

Continue Reading